Buffalo BioLabs develops customized preclinical studies for oncology, immunology, infectious disease, and related therapeutic areas. Capabilities include syngeneic and xenograft tumor models, immune profiling, flow cytometry, cell-based assays, imaging, and biomarker analysis. Its scientists collaborate with sponsors on model selection and study design so that experiments address the mechanism of action and translational questions most relevant to each therapeutic program.
Buffalo BioLabs, LLC
Buffalo BioLabs is a contract research organization (CRO) focused on preclinical oncology and immunology research, providing specialized in vitro and in vivo models for drug efficacy evaluation. Their expert scientific team offers tailored assay development, flow cytometry, and animal disease modeling to help biotech and pharma companies transition therapeutic candidates into the clinic.
